141 related articles for article (PubMed ID: 17128101)
21. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R.
Kasarskis EJ; Dempsey-Hall L; Thompson MM; Luu LC; Mendiondo M; Kryscio R
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):50-4. PubMed ID: 16036426
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of a self-administered version of the ALSFRS-R.
Montes J; Levy G; Albert S; Kaufmann P; Buchsbaum R; Gordon PH; Mitsumoto H
Neurology; 2006 Oct; 67(7):1294-6. PubMed ID: 17030772
[TBL] [Abstract][Full Text] [Related]
23. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials.
Rutkove SB; Zhang H; Schoenfeld DA; Raynor EM; Shefner JM; Cudkowicz ME; Chin AB; Aaron R; Shiffman CA
Clin Neurophysiol; 2007 Nov; 118(11):2413-8. PubMed ID: 17897874
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of resistance exercise in individuals with ALS.
Bello-Haas VD; Florence JM; Kloos AD; Scheirbecker J; Lopate G; Hayes SM; Pioro EP; Mitsumoto H
Neurology; 2007 Jun; 68(23):2003-7. PubMed ID: 17548549
[TBL] [Abstract][Full Text] [Related]
25. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
26. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
[TBL] [Abstract][Full Text] [Related]
27. Quantitating progression in ALS.
de Carvalho M; Scotto M; Lopes A; Swash M
Neurology; 2005 May; 64(10):1783-5. PubMed ID: 15911812
[TBL] [Abstract][Full Text] [Related]
28. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
29. The effect of repetitive transcranial magnetic stimulation on motor performance, fatigue and quality of life in amyotrophic lateral sclerosis.
Zanette G; Forgione A; Manganotti P; Fiaschi A; Tamburin S
J Neurol Sci; 2008 Jul; 270(1-2):18-22. PubMed ID: 18304580
[TBL] [Abstract][Full Text] [Related]
30. [Introduction of amyotrophic lateral sclerosis self-assessment scale].
Xi H; Huang H; Chen L; Wang Q; Chen D; Zhang J; Zhang F; Liu Y; Liu R; Jiang Z; Xie Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Sep; 22(9):1100-1. PubMed ID: 18822738
[TBL] [Abstract][Full Text] [Related]
31. Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials.
Andres PL; Skerry LM; Munsat TL; Thornell BJ; Szymonifka J; Schoenfeld DA; Cudkowicz ME
Muscle Nerve; 2012 Jan; 45(1):81-5. PubMed ID: 22190312
[TBL] [Abstract][Full Text] [Related]
32. [Handicap and quality of life evaluation in amyotrophic lateral sclerosis].
Sancho PO; Boisson D
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S205-4S207. PubMed ID: 17128112
[TBL] [Abstract][Full Text] [Related]
33. A role for functional classification in the early identification of prognostic factors in ALS.
Rauchway AC; Kaiboriboon K; Bansal SK; Kulkantrakorn K; Guo X; Parks BJ; Hayat GR
Amyotroph Lateral Scler; 2007 Aug; 8(4):214-6. PubMed ID: 17653918
[TBL] [Abstract][Full Text] [Related]
34. Auditory event-related potentials in non-demented patients with sporadic amyotrophic lateral sclerosis.
Raggi A; Consonni M; Iannaccone S; Perani D; Zamboni M; Sferrazza B; Cappa SF
Clin Neurophysiol; 2008 Feb; 119(2):342-50. PubMed ID: 18055257
[TBL] [Abstract][Full Text] [Related]
35. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
[TBL] [Abstract][Full Text] [Related]
36. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
Desport JC; Marin B; Funalot B; Preux PM; Couratier P
Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
[TBL] [Abstract][Full Text] [Related]
37. Accurate ALSFRS-R scores can be generated from retrospective review of clinic notes.
Lechtzin N; Maragakis NJ; Kimball R; Busse A; Hoffman V; Clawson L
Amyotroph Lateral Scler; 2009 Aug; 10(4):244-7. PubMed ID: 18985465
[TBL] [Abstract][Full Text] [Related]
38. The Neurophysiological Index in ALS.
Swash M; de Carvalho M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():108-10. PubMed ID: 15512888
[TBL] [Abstract][Full Text] [Related]
39. Clinical trials in ALS: measurement and natural history.
Munsat TL; Hollander D; Andres P; Finison L
Adv Neurol; 1991; 56():515-9. PubMed ID: 1853780
[No Abstract] [Full Text] [Related]
40. [Frontal lobe dysfunction in ALS].
Alcaz S; Apostolski S
Srp Arh Celok Lek; 1995; 123(9-10):266-70. PubMed ID: 17974446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
